# CDC 2023 Hepatitis B Screening and Testing Recommendations

OpenHBV source page: https://openhbv.bangbo.dev/sources/cdc-2023-hepatitis-b-screening-and-testing-recommendations?locale=zh-CN
Canonical Markdown: https://openhbv.bangbo.dev/sources/cdc-2023-hepatitis-b-screening-and-testing-recommendations.md?locale=zh-CN
Original source URL: https://www.cdc.gov/mmwr/volumes/72/rr/rr7201a1.htm

## Metadata

- Organization: Centers for Disease Control and Prevention
- Country or region: United States
- Language: en
- Source type: guideline
- Published: not listed
- Updated: not listed
- Last checked by OpenHBV: 2026-06-26
- Credibility note: 国家公共卫生机构

## Summary

CDC 2023 年乙肝筛查和检测建议，包含成人一次性三项筛查，以及接受或需要细胞毒性、免疫抑制或免疫调节治疗人群的检测建议。

## Related OpenHBV Articles

- Hepatitis B dengan HIV atau hepatitis C: pemeriksaan, obat, dan poin kontrol
  URL: https://openhbv.bangbo.dev/articles/hepatitis-b-dengan-hiv-atau-hepatitis-c-pemeriksaan-obat-dan-poin-kontrol?locale=zh-CN
  Markdown: https://openhbv.bangbo.dev/articles/hepatitis-b-dengan-hiv-atau-hepatitis-c-pemeriksaan-obat-dan-poin-kontrol.md?locale=zh-CN
  Summary: Apa yang perlu disiapkan saat hepatitis B tumpang tindih dengan HIV, hepatitis C, atau keputusan terapi terkait, dan mengapa obat aktif HBV tidak boleh dihentikan sendiri.
- Hepatitis B with HIV or hepatitis C: tests, medicines, and follow-up points
  URL: https://openhbv.bangbo.dev/articles/hepatitis-b-with-hiv-or-hepatitis-c-tests-medicines-and-follow-up-points?locale=zh-CN
  Markdown: https://openhbv.bangbo.dev/articles/hepatitis-b-with-hiv-or-hepatitis-c-tests-medicines-and-follow-up-points.md?locale=zh-CN
  Summary: What to prepare when hepatitis B overlaps with HIV, hepatitis C, or related treatment decisions, and why HBV-active medicines should not be stopped on your own.
- 乙肝合并 HIV 或丙肝：检查、用药和复诊要点
  URL: https://openhbv.bangbo.dev/articles/hiv?locale=zh-CN
  Markdown: https://openhbv.bangbo.dev/articles/hiv.md?locale=zh-CN
  Summary: 解释 HBsAg 阳性或 anti-HBc 阳性的人在 HIV、丙肝或相关治疗场景中应准备哪些检查，为什么不能自行停含 HBV 活性的药，以及丙肝治疗前为什么要提醒医生乙肝结果。
- Sebelum kemoterapi, imunosupresi, atau biologik: jangan lewatkan risiko reaktivasi hepatitis B
  URL: https://openhbv.bangbo.dev/articles/sebelum-kemoterapi-imunosupresi-atau-biologik-jangan-lewatkan-risiko-reaktivasi-hepatitis-b?locale=zh-CN
  Markdown: https://openhbv.bangbo.dev/articles/sebelum-kemoterapi-imunosupresi-atau-biologik-jangan-lewatkan-risiko-reaktivasi-hepatitis-b.md?locale=zh-CN
  Summary: Arti reaktivasi HBV, terapi apa yang perlu memicu skrining, dan pertanyaan sebelum terapi kanker atau penekan imun dimulai.
- Before chemotherapy, immunosuppression, or biologics: do not miss hepatitis B reactivation risk
  URL: https://openhbv.bangbo.dev/articles/before-chemotherapy-immunosuppression-or-biologics-do-not-miss-hepatitis-b-reactivation-risk?locale=zh-CN
  Markdown: https://openhbv.bangbo.dev/articles/before-chemotherapy-immunosuppression-or-biologics-do-not-miss-hepatitis-b-reactivation-risk.md?locale=zh-CN
  Summary: What HBV reactivation means, which treatments should trigger screening, and what to ask before cancer or immune-suppressing therapy starts.
- 化疗、免疫抑制或生物制剂前：别漏掉乙肝再激活风险
  URL: https://openhbv.bangbo.dev/articles/0b506371-1bb1-4719-ba5e-7f82c8cc30c0?locale=zh-CN
  Markdown: https://openhbv.bangbo.dev/articles/0b506371-1bb1-4719-ba5e-7f82c8cc30c0.md?locale=zh-CN
  Summary: 解释什么是乙肝再激活，哪些治疗前要主动筛查乙肝，以及如何把检查、用药和复查问题提前问清楚。

## Use Notes

This page is a source record, not medical advice. Use the original source URL above to verify claims, publication details, and updates. OpenHBV records the last checked date so readers and LLM retrieval systems can judge freshness.